Anemia is a typical manifestation of Plasmodium vivax infection and one of the leading causes of morbidity and mortality, particularly in pregnant women and children less than five years old. Despite the magnitude of the problem, there remain major unsolved questions about its etiology. In this context, we have addressed the following question: Are antibodies directed to erythrocyte membrane proteins involved in the accelerated clearance of red blood cells (RBCs) by phagocytes leading to anemia during P. vivax infection? We performed immunoproteomic assays trying to characterize proteins that are targets of antibodies. Sera from four groups of subjects were tested against a noninfected O+ erythrocyte membrane extract and are included in our study: P. vivax anemic individuals (PvAN); P. vivax non-anemic individuals (PvNA); non-infected individuals with anemia by other etiologies (NIAN); and noninfected and non-anemic individuals (NINA). Immunoblots revealed a differential pattern of RBC protein recognition related to the four studied groups. The breadth and the magnitude of antibody responses against RBC membrane antigens were higher in NAPv and ANPv, corroborating our previous results obtained by ELISA and 1-D immunoblot. Now, these proteins are being identified by peptide mass fingerprint. Next, we will confirm their identity by MALDI TOF/MS-MS, validate and categorize them in relation to location, family and function. Highly immunogenic and differentially recognized proteins will represent potential candidates for diagnostic or prognostic biomarkers of anemia in P. vivax infections. Moreover, data generated here will contribute to the better understanding of mechanisms enrolled in vivax anemia pathogenesis.
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